Birken AG Report issue

For profit Phase 3
Founded: Niefern-Öschelbronn Germany (2012)
Status: Acquired by Amryt Research Limited (2016)

Organization Overview

First Clinical Trial
2012
NCT00786994
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree